Health & Medical · Week of Oct 26, 2026
Abbott's MRD test and Florida vein clinics: the week in health
Two Florida vein clinics, an Abbott cancer-monitoring test, a Southeast Asia neurotech push and market forecasts led a mixed week.
There was no single theme across this week's health and medical releases. The largest product item came from Abbott, which launched a next-generation version of its Oncodetect molecular residual disease test built on whole-genome sequencing. Healthcare Triangle said it is entering neurotechnology AI devices and solutions, starting with Malaysia and Indonesia. United Vein & Vascular Centers opened two Florida clinics on the same day, in Brandon and Vero Beach.
On the corporate side, 111, Inc. said the special committee of its board has appointed an independent financial advisor and legal counsel. Boston Scientific said it will present at Stifel's 2026 Healthcare Conference. DelveInsight and MarketsandMarkets issued forecasts for the JAK inhibitors and patient registry software markets.
Abbott
Abbott launches whole-genome sequencing Oncodetect® molecular residual disease (MRD) test to detect traces of cancer during and after treatment
Abbott launched a next-generation Oncodetect molecular residual disease (MRD) test that uses whole-genome sequencing and MAESTRO technology to detect traces of cancer during and after treatment. The company says the test tracks up to 5,000 patient-specific variants, with a limit of detection below one part per million under high-end inputs.
Healthcare Triangle, Inc.
Healthcare Triangle Enters Neurotechnology AI Devices and Solutions for Southeast Asia
Healthcare Triangle, Inc. said it is entering neurotechnology AI devices and solutions for Southeast Asia, starting with Malaysia and Indonesia. The company says the two countries are home to more than 310 million people, and its initiative combines neuroscience devices, professional education and AI-supported mental healthcare.
111, Inc.
111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee
111, Inc. (NASDAQ: YI) announced that its special committee of three independent directors has appointed an independent financial advisor and legal counsel. The company describes itself as a tech-enabled healthcare platform company in China.
Boston Scientific Corporation
Boston Scientific to participate in Stifel's 2026 Healthcare Conference
Boston Scientific Corporation (NYSE: BSX) will participate in Stifel's 2026 Healthcare Conference on Wednesday, November 11, 2026. The company says Kenneth Stein, M.D., senior vice president and global chief medical officer, and Lance Bates, an executive vice president, will represent it.
DelveInsight Business Research, LLP
JAK Inhibitors Market to Register Notable Growth During the Forecast Period (2026-2036) Through Expanding Clinical and Commercial Landscape | DelveInsight
DelveInsight says the JAK inhibitors market is expected to grow steadily over the 2026-2036 forecast period. The firm attributes this to rising prevalence of autoimmune and inflammatory diseases, wider adoption of targeted therapies and expanding clinical use of JAK inhibitors across multiple indications.
MarketsandMarkets
Patient Registry Software Market worth $3.99 billion by 2031 - Exclusive Report by MarketsandMarkets™
MarketsandMarkets projects that the patient registry software market will reach USD 3.99 billion by 2031, up from USD 2.47 billion in 2026. The firm puts the compound annual growth rate at 10.0% over the forecast period.
United Vein & Vascular Centers
United Vein & Vascular Centers Opens Brandon Vein Clinic, Expanding Access Across Eastern Hillsborough County
United Vein & Vascular Centers opened a vein clinic at 517 Eichenfeld Dr., Suite 106, Brandon, FL 33511, which began seeing patients on Oct. 26, 2026. The company says the clinic offers vein screenings and diagnostic evaluations and expands access across Eastern Hillsborough County.
United Vein & Vascular Centers
United Vein & Vascular Centers Brings Specialized Vein Care to Vero Beach's Medical District
United Vein & Vascular Centers also opened a vein clinic at 3755 7th Terrace, Suite 202, in Vero Beach's medical district, which began seeing patients on Oct. 26, 2026. The company says the clinic offers vein screenings and diagnostic evaluations.
This roundup is written with AI assistance from the press releases listed above, using only what they state. The releases are the companies' own announcements, not Times Beats reporting.